SCHEMBL24908331

SCHEMBL24908331

Bc1c(B)c(B)c2c(-c3ccc4oc5cc6ccccc6cc5c4c3)c3c(B)c(B)c(B)c(B)c3c(-c3cccc(-c4cccc5ccc6ccccc6c45)c3)c2c1B

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ESR1 P03372 1/20 0.36
POLB P06746 1/20 0.36
ABCG2 Q9UNQ0 7/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
AHR P35869 4/20 0.35
PAX8 Q06710 2/20 0.35
CYP1A1 P04798 2/20 0.35
CYP1A2 P05177 2/20 0.35
FYN P06241 1/20 0.35
MAPK3 P27361 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25035906 0.94 MAPT (0.36) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL25789641 0.92 ALDH1A1 (0.36) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL24908333 0.89 ALDH1A1 (0.38) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL25035879 0.88 ALOX5 (0.36) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL21940341 0.88 ALDH1A1 (0.35) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL24766815 0.87 KDM4E (0.37) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL24908230 0.87 ALDH1A1 (0.34) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL21940511 0.86 ENPP3 (0.34) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL25789710 0.86 HSD17B1 (0.37) MAPTALDH1A1KDM4EESR1ABCG2
SCHEMBL25683352 0.85 MAOB (0.34) MAPTALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS MRPS22, RER1, EMC2 MAPT 3554/4885ALDH1A1 1929/4885KDM4E 2476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.